Pure Bioscience's total assets for Q2 2025 were $574.00K, a decrease of -37.88% from the previous quarter. PURE total liabilities were $4.84M for the fiscal quarter, a 9.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.